{"content":"<li class=\"n-box-item date-title\" data-end=\"1489463999\" data-start=\"1489377600\" data-txt=\"Sunday, December 22, 2019\">Monday, March 13, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3250810\" data-ts=\"1489449778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ON\" target=\"_blank\">ON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250810-on-semiconductor-proposes-500m-convertible-senior-note-private-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ON Semiconductor proposes $500M convertible senior note private offering</a></h4><ul><li><a href=\"http://www.onsemi.com/PowerSolutions/newsItem.do?article=3766\" target=\"_blank\">To be due 2023</a>, notes are for exclusive offer among qualified institutional purchasers. Option (30-day) for sale of additional $75M aggregate principal amount also granted to initial buyers.</li><li>Proceeds are intended for repayment of outstanding debt under term loan B facility and payment of associated transaction fees and expenses.</li><li>ON Semiconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a>) $15.05,&nbsp;<font color='red'>-1.7%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250810\" data-linked=\"ON Semiconductor proposes $500M convertible senior note private offering\" data-tweet=\"$ON - ON Semiconductor proposes $500M convertible senior note private offering https://seekingalpha.com/news/3250810-on-semiconductor-proposes-500m-convertible-senior-note-private-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3250810-on-semiconductor-proposes-500m-convertible-senior-note-private-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250807\" data-ts=\"1489444636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250807-analyst-blackberry-see-comeback-via-infrastructure-projects\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst: BlackBerry could see comeback via infrastructure projects</a></h4><ul>   <li>BlackBerry (<a href=\"https://seekingalpha.com/symbol/BBRY\" target=\"_blank\">BBRY</a> <font color='green'>+2.6%</font>) may be <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/03/9164270/a-bullish-case-for-blackberry-as-an-anti-trend-play\" target=\"_blank\">poised for a comeback</a>, Global Equities Research suggests, and the unlikely benefactor may be the priorities coming from the new presidential administration.</li>    <li>Analyst Trip Chowdhry reiterated an Overweight rating noting that the company is in good position for a central role in $1 trillion in proposed infrastructure spending.</li>    <li>&ldquo;BBRY can be the intelligent infrastructure system provider for the new collar industry\" -- next-gen jobs that are a hybrid of blue collar and white collar -- \"which we think could be 10% of [a] $200 billion infrastructure spend, or $20 billion,&rdquo; Chowdhry says.</li>    <li>Aside from that development, which needs a 2-3 year horizon, quarterly numbers mean \"nothing,\" Chowdhry says.</li>    <li>Chowdhry has an $11 price target, implying 57% upside from today's close.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250807\" data-linked=\"Analyst: BlackBerry could see comeback via infrastructure projects\" data-tweet=\"$BB - Analyst: BlackBerry could see comeback via infrastructure projects https://seekingalpha.com/news/3250807-analyst-blackberry-see-comeback-via-infrastructure-projects?source=tweet\" data-url=\"https://seekingalpha.com/news/3250807-analyst-blackberry-see-comeback-via-infrastructure-projects\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>92&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250805\" data-ts=\"1489444173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICON\" target=\"_blank\">ICON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250805-iconix-brand-group-affiliate-sued-for-90m-in-damages\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iconix Brand Group affiliate sued for $90M in damages</a></h4><ul> <li>A lawsuit has been filed against Iconix Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a>) affiliate Umbro IP Holdings in the state of New York by Premier Goal Club and Balanced Tech Corp.</li> <li>The action alleges that Iconix breached trademark licensing arrangements with respect to the Umbro trademark and entered a new licensing agreement with a major retailer unjustly.</li> <li>The plaintiffs are asking for an award of compensatory damages of just under $90M combined.</li> <li><a href=\"https://iapps.courts.state.ny.us/nyscef/ViewDocument?docIndex=eYadrDtlqsmNtg/Nt5LKGg==\" target=\"_blank\">Filing with the New York court system</a></li><li>Shares of Iconix&nbsp;<font color='red'>fell 2.70%</font>&nbsp;today.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3250805\" data-linked=\"Iconix Brand Group affiliate sued for $90M in damages\" data-tweet=\"$ICON - Iconix Brand Group affiliate sued for $90M in damages https://seekingalpha.com/news/3250805-iconix-brand-group-affiliate-sued-for-90m-in-damages?source=tweet\" data-url=\"https://seekingalpha.com/news/3250805-iconix-brand-group-affiliate-sued-for-90m-in-damages\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>152&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250794\" data-ts=\"1489441218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250794-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/RT' title='Ruby Tuesday, Inc.'>RT</a> <font color='green'>+20.7%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='green'>+4.6%</font>. <a href='https://seekingalpha.com/symbol/INAP' title='Internap Network Services Corporation'>INAP</a> <font color='green'>+4.3%</font>. <a href='https://seekingalpha.com/symbol/EQGP' title='EQT GP Holdings LP'>EQGP</a> <font color='green'>+2.9%</font>. <a href='https://seekingalpha.com/symbol/REN' title='Resolute Energy Corporation'>REN</a> <font color='green'>+2.4%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='red'>-17.4%</font>. <a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a> <font color='red'>-12.9%</font>. VRX <font color='red'>-10.0%</font>. <a href='https://seekingalpha.com/symbol/AMPH' title='Amphastar'>AMPH</a> <font color='red'>-5.0%</font>. <a href='https://seekingalpha.com/symbol/DOC' title='Physicians Realty Trust'>DOC</a> <font color='red'>-3.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250794\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$RT $MNKD $INAP - After Hours Gainers / Losers https://seekingalpha.com/news/3250794-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3250794-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250788\" data-ts=\"1489439525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRWI\" target=\"_blank\">DRWI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250788-dragonwave-rises-double-digits-on-australia-distribution-pact\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DragonWave rises double digits on Australia distribution pact</a></h4><ul>   <li>DragonWave (<a href='https://seekingalpha.com/symbol/DRWI' title='DragonWave Inc.'>DRWI</a> <font color='green'>+9.5%</font>), recently the subject of volatile trading, is <font color='green'>up 17.4%</font> in light postmarket action after announcing a <a href=\"https://seekingalpha.com/pr/16769795-dragonwave-announces-distribution-partnership-ingram-micro-australia\" target=\"_blank\">distribution deal with Ingram Micro Australia</a>.</li>    <li>The new master sales and services agreement will have Ingram Micro expand its vendor portfolio to the Australia channel, introducing DragonWave's packet microwave product portfolio -- particularly the Harmony Enhanced MC, suited for high-bandwidth rural connectivity, the company says.</li>    <li>\"Ingram Micro will help launch our new Harmony Enhanced MC product line into very important channel markets where wireless networks are playing an ever-increasing role to augment ongoing National Broadband Network fiber builds,\" says DragonWave CEO Peter Allen.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250788\" data-linked=\"DragonWave rises double digits on Australia distribution pact\" data-tweet=\"$DRWI - DragonWave rises double digits on Australia distribution pact https://seekingalpha.com/news/3250788-dragonwave-rises-double-digits-on-australia-distribution-pact?source=tweet\" data-url=\"https://seekingalpha.com/news/3250788-dragonwave-rises-double-digits-on-australia-distribution-pact\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250782\" data-ts=\"1489438957\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250782-needham-boosts-arista-price-target-on-new-software-strategy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham boosts Arista price target on new software strategy</a></h4><ul>   <li>Arista Networks (<a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a> <font color='green'>+2.7%</font>) has an advantage in its software strategy that gives it an <a href=\"http://www.investors.com/news/technology/arista-networks-price-target-hiked-on-software-strategy/\" target=\"_blank\">edge on rival Cisco Systems</a> (<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a> <font color='red'>-0.5%</font>), Needham says.</li>    <li>The firm boosted its price target on Arista to $150 from $130, implying near-18% upside from today's close.</li>    <li>A \"containerized\" EOS operating system allows for running on white box hardware, part of a strategy that \"really matters to the Web 2.0 customers; Cisco Systems can't match it,\" writes Needham's Alex Henderson.</li>    <li>The two companies are awaiting an ITC hearing in April tied to ongoing patent litigation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250782\" data-linked=\"Needham boosts Arista price target on new software strategy\" data-tweet=\"$CSCO $CSCO $ANET - Needham boosts Arista price target on new software strategy https://seekingalpha.com/news/3250782-needham-boosts-arista-price-target-on-new-software-strategy?source=tweet\" data-url=\"https://seekingalpha.com/news/3250782-needham-boosts-arista-price-target-on-new-software-strategy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250776\" data-ts=\"1489437659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNTH\" target=\"_blank\">LNTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250776-lantheus-readies-stock-offering-existing-shareholders-shares-ease-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lantheus readies stock offering by existing shareholders; shares ease 1% after hours</a></h4><ul><li>Lantheus Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/LNTH' title='Lantheus Holdings'>LNTH</a>) slips&nbsp;<font color='red'>1%&nbsp;</font>after hours on light volume in response to its <a href=\"https://seekingalpha.com/pr/16769728-lantheus-holdings-inc-announces-public-secondary-offering-3000-000-shares-common-stock\" target=\"_blank\">announcement </a>of a public offering of common shares from existing stockholders. Price, volume and terms have yet to be announced. The company will receive no proceeds from the offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250776\" data-linked=\"Lantheus readies stock offering by existing shareholders; shares ease 1% after hours\" data-tweet=\"$LNTH - Lantheus readies stock offering by existing shareholders; shares ease 1% after hours https://seekingalpha.com/news/3250776-lantheus-readies-stock-offering-existing-shareholders-shares-ease-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3250776-lantheus-readies-stock-offering-existing-shareholders-shares-ease-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250766\" data-ts=\"1489436703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250766-ackman-bails-on-valeant-shares-off-8-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ackman bails on Valeant; shares off 8% after hours</a></h4><ul><li>Long-time Valeant Pharmaceuticals (VRX) bull Bill Ackman has apparently waved the white flag. CNBC <a href=\"http://www.cnbc.com/2017/03/13/ackman-has-sold-out-of-valeant-will-step-down-from-board-sources.html\" target=\"_blank\">reports </a>that he sold 27.2M shares at ~$11 and will be quitting the board. Developing....</li><li>Shares are down&nbsp;<font color='red'>8%</font>&nbsp;after hours on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250766\" data-linked=\"Ackman bails on Valeant; shares off 8% after hours\" data-tweet=\"$BHC - Ackman bails on Valeant; shares off 8% after hours https://seekingalpha.com/news/3250766-ackman-bails-on-valeant-shares-off-8-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3250766-ackman-bails-on-valeant-shares-off-8-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>699&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250765\" data-ts=\"1489436683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RT\" target=\"_blank\">RT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250765-strategic-alternatives-ruby-tuesday-shares-up-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Strategic alternatives at Ruby Tuesday shares up 15%</a></h4><ul><li>The <a href=\"https://seekingalpha.com/pr/16769686-ruby-tuesday-inc-explore-strategic-alternatives\" target=\"_blank\">company has retained </a>UBS to assist.</li><li>Alongside, preliminary FQ3 results (ended Feb. 28) show same-store sales down about 4%.</li><li><a href='https://seekingalpha.com/symbol/RT' title='Ruby Tuesday, Inc.'>RT</a>&nbsp;<font color='green'>+14.9%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3250765\" data-linked=\"Strategic alternatives at Ruby Tuesday shares up 15%\" data-tweet=\"$RT - Strategic alternatives at Ruby Tuesday shares up 15% https://seekingalpha.com/news/3250765-strategic-alternatives-ruby-tuesday-shares-up-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3250765-strategic-alternatives-ruby-tuesday-shares-up-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250760\" data-ts=\"1489436457\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLYS\" target=\"_blank\">TLYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250760-tillys-down-10-after-dour-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tilly&#39;s down 10% after dour outlook</a></h4><ul><li>The company topped Q4 estimates, but says quarter-to-date comp sales, including e-commerce sales have fallen by a high single-digit percentage thanks to a later Easter and significant weather issues in CA, AZ, and NV.</li><li>Management expects Q1 comp sales to be down by low-to-mid single-digit percentage, operating loss of $3M-$7M, and loss per share of $0.07-$0.15 vs. $0.10 loss in FQ1 of 2016.</li><li><a href=\"http://www.tillys.com\" target=\"_blank\">Conference call at 4:30 ET</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3250737-tillys-beats-0_01-beats-revenue\" target=\"_blank\">Tilly's beats by $0.01, beats on revenue</a> (March 13)</li><li><a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a>&nbsp;<font color='red'>-9.9%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3250760\" data-linked=\"Tilly&#39;s down 10% after dour outlook\" data-tweet=\"$TLYS - Tilly&#39;s down 10% after dour outlook https://seekingalpha.com/news/3250760-tillys-down-10-after-dour-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3250760-tillys-down-10-after-dour-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250758\" data-ts=\"1489436418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUPH\" target=\"_blank\">AUPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250758-aurinia-readies-equity-offering-shares-ease-8-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurinia readies equity offering; shares ease 8% after hours</a></h4><ul><li>Aurinia Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a>) slips&nbsp;<font color='red'>8%</font>&nbsp;after hours on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16769669-aurinia-announces-public-offering-common-shares\" target=\"_blank\">planned public offering</a> of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250758\" data-linked=\"Aurinia readies equity offering; shares ease 8% after hours\" data-tweet=\"$AUPH - Aurinia readies equity offering; shares ease 8% after hours https://seekingalpha.com/news/3250758-aurinia-readies-equity-offering-shares-ease-8-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3250758-aurinia-readies-equity-offering-shares-ease-8-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250755\" data-ts=\"1489436250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANTH\" target=\"_blank\">ANTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250755-anthera-pharma-launches-equity-offering-shares-drop-28-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anthera Pharma launches equity offering; shares drop 28% after hours</a></h4><ul><li>Anthera Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ANTH' title='Anthera Pharmaceuticals, Inc.'>OTC:ANTH</a>) slumps&nbsp;<font color='red'>28%</font>&nbsp;after hours on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16769672-anthera-pharmaceuticals-announces-proposed-public-offering-common-stock-warrants\" target=\"_blank\">announcement </a>of a public offering of common stock. Price, volume and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250755\" data-linked=\"Anthera Pharma launches equity offering; shares drop 28% after hours\" data-tweet=\"$ANTH - Anthera Pharma launches equity offering; shares drop 28% after hours https://seekingalpha.com/news/3250755-anthera-pharma-launches-equity-offering-shares-drop-28-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3250755-anthera-pharma-launches-equity-offering-shares-drop-28-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250745\" data-ts=\"1489435892\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOC\" target=\"_blank\">DOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250745-physicians-realty-trustminus-4-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Physicians realty Trust -4% on capital raise</a></h4><ul><li>The<a href=\"https://seekingalpha.com/pr/16769699-physicians-realty-trust-announces-public-offering-15000-000-common-shares\" target=\"_blank\"> company is selling</a> 15M shares with underwriter greenshoe for another 2.25M shares.</li><li><a href='https://seekingalpha.com/symbol/DOC' title='Physicians Realty Trust'>DOC</a>&nbsp;<font color='red'>-4%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3250745\" data-linked=\"Physicians realty Trust -4% on capital raise\" data-tweet=\"$DOC - Physicians realty Trust -4% on capital raise https://seekingalpha.com/news/3250745-physicians-realty-trustminus-4-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3250745-physicians-realty-trustminus-4-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250728\" data-ts=\"1489434944\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTXS\" target=\"_blank\">CTXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250728-citrix-systemsplus-7_3-work-goldman-sachs-involving-exploration-of-sale-reported-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citrix Systems +7.3%; work with Goldman Sachs involving exploration of sale reported [updated]</a></h4><ul><li><a href=\"https://www.bloomberg.com/news/articles/2017-03-13/citrix-is-working-with-goldman-sachs-on-potential-sale-process\" target=\"_blank\">Full story</a> [Bloomberg].</li><li>Citrix Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CTXS' title='Citrix Systems, Inc.'>CTXS</a>) $85.80.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250728\" data-linked=\"Citrix Systems +7.3%; work with Goldman Sachs involving exploration of sale reported [updated]\" data-tweet=\"$CTXS - Citrix Systems +7.3%; work with Goldman Sachs involving exploration of sale reported [updated] https://seekingalpha.com/news/3250728-citrix-systemsplus-7_3-work-goldman-sachs-involving-exploration-of-sale-reported-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3250728-citrix-systemsplus-7_3-work-goldman-sachs-involving-exploration-of-sale-reported-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250724\" data-ts=\"1489434353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LJPC\" target=\"_blank\">LJPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250724-lajolla-pharma-under-pressure-on-questions-ljpcminus-501s-mortality-benefit-shares-slip-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LaJolla Pharma under pressure on questions about LJPC-501&#39;s mortality benefit; shares slip 2%</a></h4><ul><li>La Jolla Pharmaceuticals (<a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Co.'>LJPC</a> <font color='red'>-1.9%</font>) has been the red almost all session. According to <a href=\"https://www.biocentury.com/biocentury/product-development/2017-03-10/different-views-la-jollas-ljpc-501-data-investors-doctors?kwh=%22angiotensin+II%22+%22LJPC-501%22\" target=\"_blank\">BioCentury</a>, doctors are questioning the efficacy of treatment-resistant hypotension candidate LJPC-501 (angiotensin II). Last month, the company announced the successful outcome of a Phase 3 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02338843?term=ljpc-501&amp;phase=2&amp;rank=1\" target=\"_blank\">ATHOS-3</a>, assessing LJPC-501 for the treatment of a life-threatening drop in blood pressure called catecholamine-resistant hypotension &#40;CRH&#41;. The trial met its primary endpoint of demonstrating a statistically valid proportion of patients who achieved a target blood pressure response.</li><li>Clinicians, however, are keen to know LJPC-501's effect on mortality, which ATHOS-3 could not show since it was not powered to do so.</li><li><a href=\"http://lajollapharmaceutical.com/product-pipeline/ljpc-501/\" target=\"_blank\">LJPC-501</a>&nbsp;is a proprietary formulation of&nbsp;<a href=\"http://en.wikipedia.org/wiki/Angiotensin\" target=\"_blank\">angiotensin II</a>, which acts to stabilize blood pressure and help the kidneys balance body fluids and electrolytes.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3246726-la-jollas-angiotensin-ii-successful-late-stage-study-shares-ahead-73-percent\" target=\"_blank\">La Jolla's angiotensin II successful in late-stage study; shares ahead 73%</a> (Feb. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3250724\" data-linked=\"LaJolla Pharma under pressure on questions about LJPC-501&#39;s mortality benefit; shares slip 2%\" data-tweet=\"$LJPC - LaJolla Pharma under pressure on questions about LJPC-501&#39;s mortality benefit; shares slip 2% https://seekingalpha.com/news/3250724-lajolla-pharma-under-pressure-on-questions-ljpcminus-501s-mortality-benefit-shares-slip-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3250724-lajolla-pharma-under-pressure-on-questions-ljpcminus-501s-mortality-benefit-shares-slip-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250714\" data-ts=\"1489431859\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250714-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PRKR' title='ParkerVision, Inc.'>OTC:PRKR</a> <font color='green'>+-17%</font>. <a href='https://seekingalpha.com/symbol/CRDS' title='Crossroads Systems, Inc.'>CRDS</a> <font color='green'>+-14%</font>. <a href='https://seekingalpha.com/symbol/NCR' title='NCR Corporation'>NCR</a> <font color='green'>+-11%</font>. <a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a> <font color='green'>+-11%</font>. <a href='https://seekingalpha.com/symbol/TNGO' title='Tangoe'>OTC:TNGO</a> <font color='green'>+-8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PRKR' title='ParkerVision, Inc.'>OTC:PRKR</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CRDS' title='Crossroads Systems, Inc.'>CRDS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/NCR' title='NCR Corporation'>NCR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TNGO' title='Tangoe'>OTC:TNGO</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250714\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$PRKR $CRDS $NCR - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3250714-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3250714-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250712\" data-ts=\"1489431433\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIG\" target=\"_blank\">RIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250712-transocean-extends-gains-may-be-near-1_2b-deal-to-sell-15-rigs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transocean extends gains as may be near $1.2B deal to sell 15 rigs</a></h4><ul><li>Transocean (<a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='green'>+1.9%</font>) is up another 2% after Friday's similar gain, which apparently was sparked by reports that it was <a href=\"http://www.upstreamonline.com/live/1224633/borr-has-transocean-rigs-in-sights\" target=\"_blank\">near a deal for a $1.2B sale</a> of its fleet of shallow-water rigs.</li><li>The potential deal reportedly would include RIG&rsquo;s entire active fleet of 10 high-specification jack-ups plus another five newbuilds under construction for a total $1.2B; excluding the $290M already paid for the newbuilds, Evercore ISI's James West says the reported purchase price averages to $120M/jackup and is well above its bull case estimate</li><li>Evercore says it would be \"<a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/03/13/transocean-be-aggressive/\" target=\"_blank\">aggressive buyers</a>\" of RIG if the deal materializes, as it would monetize an under-utilized jackup fleet that averages 13.5 years of age and eliminate a large chunk of future newbuild capex.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250712\" data-linked=\"Transocean extends gains as may be near $1.2B deal to sell 15 rigs\" data-tweet=\"$RIG - Transocean extends gains as may be near $1.2B deal to sell 15 rigs https://seekingalpha.com/news/3250712-transocean-extends-gains-may-be-near-1_2b-deal-to-sell-15-rigs?source=tweet\" data-url=\"https://seekingalpha.com/news/3250712-transocean-extends-gains-may-be-near-1_2b-deal-to-sell-15-rigs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250710\" data-ts=\"1489430518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250710-ges-lagging-performance-not-all-immelts-fault-j-p-morgan-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE&#39;s lagging performance not all Immelt&#39;s fault, J.P. Morgan analyst says</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-1.6%</font>) is giving back most of its <a href=\"https://seekingalpha.com/news/3250430-fox-immelt-hot-seat-peltz-ge-nearly-2-percent\" target=\"_blank\">Friday gains</a> that were sparked by a Fox Business report that CEO&nbsp;Jeffrey Immelt is \"in the hot seat\" with Nelson Peltz and his Trian Fund.</li>     <li>GE shares have lagged the market for the past 15 years, advancing just 0.4% annually including reinvested dividends vs. a 7% return for the S&amp;P 500, and Barclays discussed an unnamed investor&rsquo;s view that the stock <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/03/10/why-general-electric-is-flying/\" target=\"_blank\">could gain 5% from a CEO change</a>, along with various other reasons to like the stock.</li><li>But J.P. Morgan's Stephen Tusa thinks the stock has struggled <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/03/13/general-electric-what-if-its-not-immelt/\" target=\"_blank\">not because of execution or something the CEO has done wrong</a>, but \"because of the stubbornly low growth and secular challenges embedded in end markets where a company of this size is forced to play, as evidenced by limited profit growth despite $8B of restructuring and significant gains since 2012.\"</li><li>Even so, Tusa prefers Danaher (<a href='https://seekingalpha.com/symbol/DHR' title='Danaher Corporation'>DHR</a> <font color='red'>-0.6%</font>), which \"gets a multiple because it generates cash and redeploys into growth from a base of revenue that is 15% of what GE is, and recently even shrunk the portfolio to reset the growth trajectory.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250710\" data-linked=\"GE&#39;s lagging performance not all Immelt&#39;s fault, J.P. Morgan analyst says\" data-tweet=\"$GE $GE $DHR - GE&#39;s lagging performance not all Immelt&#39;s fault, J.P. Morgan analyst says https://seekingalpha.com/news/3250710-ges-lagging-performance-not-all-immelts-fault-j-p-morgan-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3250710-ges-lagging-performance-not-all-immelts-fault-j-p-morgan-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250709\" data-ts=\"1489429309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GST\" target=\"_blank\">GST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250709-gastar-exploration-ready-to-buy-after-last-weeks-24-drop-canaccord-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gastar Exploration ready to buy after last week&#39;s 24% drop, Canaccord says</a></h4><ul>     <li><a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/03/9163554/with-gastar-down-25-last-week-canaccord-says-buy-the-dip\" target=\"_blank\">Buy the dip</a> in Gastar Exploration (<a href='https://seekingalpha.com/symbol/GST' title='Gastar Exploration Inc.'>GST</a> <font color='green'>+1.6%</font>), as the stock is oversold after falling 24% last week and is set to build momentum later this year and beyond, analysts at Canaccord Genuity say.</li>     <li>The firm notes GST is the only pure Mid-Continent player in Oklahoma, where it has more than 80K net surface acres with 1K-plus net STACK locations, and $425M in new financing from Ares Management cleans up the balance sheet and pushes out 2017-18 debt maturities until 2022, helping give the company more flexibility to prove out its core STACK acreage.</li>     <li>Meanwhile, Canaccord says the new development agreement positions GST to minimize leasehold renewal costs with minimal drilling capital on the company's part, while maintaining the majority of the upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250709\" data-linked=\"Gastar Exploration ready to buy after last week&#39;s 24% drop, Canaccord says\" data-tweet=\"$GST - Gastar Exploration ready to buy after last week&#39;s 24% drop, Canaccord says https://seekingalpha.com/news/3250709-gastar-exploration-ready-to-buy-after-last-weeks-24-drop-canaccord-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3250709-gastar-exploration-ready-to-buy-after-last-weeks-24-drop-canaccord-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250706\" data-ts=\"1489428409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPWH\" target=\"_blank\">SPWH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250706-sporting-goods-sector-stirred-up-again-bankruptcy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sporting goods sector stirred up again by bankruptcy</a></h4><ul> <li>Credit Suisse thinks Sportsman's Warehouse Holdings (<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='green'>+0.2%</font>) will <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/03/9163822/what-the-gander-mountain-bankruptcy-means-for-dicks-spor\" target=\"_blank\">benefit</a> from the Gander Mountain bankruptcy to a larger degree than Dick's Sporting Goods (<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a> <font color='red'>-3.7%</font>).</li> <li>The Gander bankruptcy is the largest in the sporting good sector since Sports Authority filed. Gander generated sales of $1.32B last year.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3242893-gander-mountain-said-close-bankruptcy-filing\" target=\"_blank\">Gander Mountain said to be close to bankruptcy filing</a> (Feb. 13)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3250706\" data-linked=\"Sporting goods sector stirred up again by bankruptcy\" data-tweet=\"$SPWH $SPWH $DKS - Sporting goods sector stirred up again by bankruptcy https://seekingalpha.com/news/3250706-sporting-goods-sector-stirred-up-again-bankruptcy?source=tweet\" data-url=\"https://seekingalpha.com/news/3250706-sporting-goods-sector-stirred-up-again-bankruptcy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250704\" data-ts=\"1489428047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250704-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/GPRK' title='GeoPark Ltd.'>GPRK</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/KRO' title='KRONOS Worldwide, Inc.'>KRO</a> <font color='green'>+9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250704\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$TELL $BCEI $GPRK - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3250704-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3250704-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250702\" data-ts=\"1489427894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHP\" target=\"_blank\">BHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250702-bhp-tries-again-to-get-escondida-mine-union-to-resume-negotiations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BHP tries again to get Escondida mine union to resume negotiations</a></h4><ul>     <li>BHP Billiton (<a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='green'>+2%</font>) is <a href=\"http://www.reuters.com/article/us-chile-copper-escondida-idUSKBN16K266\" target=\"_blank\">inviting striking workers</a> at its Escondida copper mine in Chile to return to the negotiating table, after a similar approach was rejected on Saturday.</li>     <li>BHP addressed the workers' grievances in a letter sent to the 2,500-member union, which says it is analyzing the letter to determine its response.</li>     <li>Escondida, the world's largest copper mine, produced a bit more than 1M metric tons of copper in 2016; it is majority owned by BHP, with Rio Tinto (<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='green'>+3.4%</font>) and Japanese companies including Mitsubishi holding minority interests.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250702\" data-linked=\"BHP tries again to get Escondida mine union to resume negotiations\" data-tweet=\"$BHP $BHP $RIO - BHP tries again to get Escondida mine union to resume negotiations https://seekingalpha.com/news/3250702-bhp-tries-again-to-get-escondida-mine-union-to-resume-negotiations?source=tweet\" data-url=\"https://seekingalpha.com/news/3250702-bhp-tries-again-to-get-escondida-mine-union-to-resume-negotiations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250701\" data-ts=\"1489427202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250701-intelminus-1_8-following-15_3b-bid-for-mobileye\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel -1.8% following $15.3B bid for Mobileye</a></h4><ul><li>Although certain strategic advantages of an Intel-Mobileye combination are evident (greater autonomous vehicle technology capacity, potential processor and vision system synergies etc.), concerns over deal pricing as well as <a href=\"http://blogs.barrons.com/techtraderdaily/2017/03/13/intel-boat-missed-in-mobile-trying-to-salvage-auto-says-susquehanna/\" target=\"_blank\">accounting</a>, sharp competition (most notably Nvidia), acquisition track record, talent retention and other execution related items are factoring into present sentiment. Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) $35.28, (<a href='https://seekingalpha.com/symbol/MBLY' title='Mobileye'>MBLY</a> <font color='green'>+29%</font>).</li><li>Earlier (March 13, 2017): <a href=\"https://seekingalpha.com/news/3250566-intel-confirms-acquisition-mobileye\" target=\"_blank\">Intel confirms acquisition of Mobileye</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3250701\" data-linked=\"Intel -1.8% following $15.3B bid for Mobileye\" data-tweet=\"$INTC $INTC $MBLY - Intel -1.8% following $15.3B bid for Mobileye https://seekingalpha.com/news/3250701-intelminus-1_8-following-15_3b-bid-for-mobileye?source=tweet\" data-url=\"https://seekingalpha.com/news/3250701-intelminus-1_8-following-15_3b-bid-for-mobileye\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250696\" data-ts=\"1489425052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250696-financials-top-5-gainers-losers-of-1-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:10 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GCAP' title='GAIN Capital Holdings, Inc.'>GCAP</a> <font color='green'>+7%</font>. WMIH <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/DMLP' title='Dorchester Minerals, L.P.'>DMLP</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/IBN' title='ICICI Bank Ltd.'>IBN</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings'>CWH</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CFFI' title='C&F Financial Corporation'>CFFI</a> <font color='red'>-6%</font>. IFMI <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250696\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:10 PM\" data-tweet=\"$GCAP $COOP $DMLP - Financials - Top 5 Gainers / Losers as of 1:10 PM https://seekingalpha.com/news/3250696-financials-top-5-gainers-losers-of-1-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3250696-financials-top-5-gainers-losers-of-1-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250695\" data-ts=\"1489424918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPOT\" target=\"_blank\">SPOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250695-pandora-ceo-companys-not-for-sale-and-is-headed-for-profit-this-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora CEO: Company&#39;s not for sale and is headed for profit this year</a></h4><ul>   <li>After the company announced its new <a href=\"https://seekingalpha.com/news/3250643-pandora-aims-spotify-apple-premium-subscription-tier\" target=\"_blank\">premium subscription service</a>, Pandora Media (<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a> <font color='green'>+0.6%</font>) chief Tim Westergren says the company <a href=\"http://www.cnbc.com/2017/03/13/westergren-pandora-premium-compatition-and-profitability.html\" target=\"_blank\">isn't for sale</a> and will fulfill a tall order in 2017: profitability.</li>    <li>Several stock moves in past months have been attributed to <a href=\"https://seekingalpha.com/news/search?query=pandora+maffei\" target=\"_blank\">commentary from Liberty's Greg Maffei</a> about whether Sirius XM (<a href='https://seekingalpha.com/symbol/SIRI' title='Sirius XM Holdings Inc.'>SIRI</a> <font color='green'>+6.2%</font>) would buy Pandora.</li>    <li>\"These are early days in the subscription of music and listeners don't know what a real premium product looks like yet and that's what Pandora is,\" he told CNBC. No one (meaning rivals Spotify (MUSIC) and Apple Music) has really solved the ease-of-use problem for subscription music, he says.</li>    <li>As for headroom on marketing spending against deep-pocketed competitors, Westergren said \"it starts with our listener base,\" suggesting Pandora can get the word out on the platform for free.</li>    <li>Pandora lost $343M last year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250695\" data-linked=\"Pandora CEO: Company&#39;s not for sale and is headed for profit this year\" data-tweet=\"$SPOT $SPOT $P - Pandora CEO: Company&#39;s not for sale and is headed for profit this year https://seekingalpha.com/news/3250695-pandora-ceo-companys-not-for-sale-and-is-headed-for-profit-this-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3250695-pandora-ceo-companys-not-for-sale-and-is-headed-for-profit-this-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>88&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250692\" data-ts=\"1489423906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STM\" target=\"_blank\">STM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250692-stmicroelectronics-components-selected-for-nintendo-switch-inclusion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">STMicroelectronics components selected for Nintendo Switch inclusion</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/16769286-semiconductor-solutions-stmicroelectronics-selected-nintendo-nintendo-switch\" target=\"_blank\">Comprising</a> STMicroelectronics' motion sensors, touch-screen controller IC, STM32 microcontrollers and NFC controller IC, the contribution is notable, especially as prior involvement with Nintendo's Wii is held by STMicroelectronics&nbsp;in&nbsp;<a href=\"http://blogs.barrons.com/techtraderdaily/2017/03/08/st-micro-a-sensing-star-is-reborn/\" target=\"_blank\">particularly high regard</a>.</li><li>STMicroelectronics (NYSE:<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a>)&nbsp;<font color='green'>+0.29%</font>,&nbsp;<font color='green'>+2%</font>&nbsp;intraday.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250692\" data-linked=\"STMicroelectronics components selected for Nintendo Switch inclusion\" data-tweet=\"$STM - STMicroelectronics components selected for Nintendo Switch inclusion https://seekingalpha.com/news/3250692-stmicroelectronics-components-selected-for-nintendo-switch-inclusion?source=tweet\" data-url=\"https://seekingalpha.com/news/3250692-stmicroelectronics-components-selected-for-nintendo-switch-inclusion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250689\" data-ts=\"1489423815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADAP\" target=\"_blank\">ADAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250689-adaptimmune-top-line-up-112-pipeline-advancing-shares-ahead-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adaptimmune top-line up 112%; pipeline advancing; shares ahead 15%</a></h4><ul><li>Adaptimmune (<a href='https://seekingalpha.com/symbol/ADAP' title='Adaptimmune Therapeutics plc'>ADAP</a> <font color='green'>+15%</font>) <a href=\"https://seekingalpha.com/pr/16768772-adaptimmune-reports-fourth-quarter-full-year-2016-financial-results\" target=\"_blank\">Q4 results</a> ($M): 8.5 (+111.8%).</li><li>Net Loss: (15.4) (+8.3%); Loss/Share: (0.04) (unch); Cash Flow Ops (12 mo.): (48.2) (-52.5%).</li><li><strong>2017 Guidance</strong>: Quick assets of $181.5M (as of 12/31/16) should be sufficient to fund operations through mid-2018.</li><li>Results beat consensus views.</li><li>Initial data on MAGE-A10 and MAGE-A4 T-cell therapies expected later this year. Four open INDs, including three SPEAR T-cells.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250689\" data-linked=\"Adaptimmune top-line up 112%; pipeline advancing; shares ahead 15%\" data-tweet=\"$ADAP - Adaptimmune top-line up 112%; pipeline advancing; shares ahead 15% https://seekingalpha.com/news/3250689-adaptimmune-top-line-up-112-pipeline-advancing-shares-ahead-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3250689-adaptimmune-top-line-up-112-pipeline-advancing-shares-ahead-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250691\" data-ts=\"1489423638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250691-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> CERU <font color='green'>+44%</font>. <a href='https://seekingalpha.com/symbol/QUMU' title='Qumu Corporation'>QUMU</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/MBLY' title='Mobileye'>MBLY</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/SGMA' title='SigmaTron International, Inc.'>SGMA</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/ADAP' title='Adaptimmune Therapeutics plc'>ADAP</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/PLX' title='Protalix BioTherapeutics, Inc'>PLX</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ARLZ-OLD' title='Aralez Pharmaceuticals Inc.'>ARLZ-OLD</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/CERC' title='Cerecor'>CERC</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/OSIR' title='Osiris Therapeutics, Inc.'>OSIR</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/HLTH' title='Nobilis Health Corp.'>HLTH</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CRDS' title='Crossroads Systems, Inc.'>CRDS</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/PRKR' title='ParkerVision, Inc.'>OTC:PRKR</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ORPN' title='Bio Blast Pharma'>ORPN</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250691\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$DARE $QUMU $MBLY - Midday Gainers / Losers https://seekingalpha.com/news/3250691-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3250691-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250688\" data-ts=\"1489423233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SALT\" target=\"_blank\">SALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250688-scorpio-bulkers-up-another-6-after-upgrdae\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scorpio Bulkers up another 6% after upgrdae</a></h4><ul><li>A doubling in the stock price over the past six months isn't scaring off Credit Suisse's Gregory Lewis, <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/03/13/scorpio-bulkers-has-doubled-in-just-six-months-this-analyst-just-upgraded-it/?mod=BOLBlog\" target=\"_blank\">who upgrades to Outperform</a> from Neutral.</li><li>\"Asset prices continue to melt-up with each transaction,\" he says.</li><li>Bulker prices are up about 30% since bottoming about a year ago, and with \"nil modern tonnage\" available, he expects prices to grind higher.</li><li>The new price target of $10 suggests about another&nbsp;<font color='green'>25% upside</font>.</li><li><a href='https://seekingalpha.com/symbol/SALT' title='Scorpio Bulkers Inc'>SALT</a>&nbsp;<font color='green'>+5.9%</font>&nbsp;to $8.10.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250688\" data-linked=\"Scorpio Bulkers up another 6% after upgrdae\" data-tweet=\"$SALT - Scorpio Bulkers up another 6% after upgrdae https://seekingalpha.com/news/3250688-scorpio-bulkers-up-another-6-after-upgrdae?source=tweet\" data-url=\"https://seekingalpha.com/news/3250688-scorpio-bulkers-up-another-6-after-upgrdae\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250686\" data-ts=\"1489422574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSIR\" target=\"_blank\">OSIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250686-trading-in-osiris-therapeutics-to-be-suspended-tomorrow-formal-delisting-to-follow-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading in Osiris Therapeutics to be suspended tomorrow, formal delisting to follow; shares slump 19%</a></h4><ul><li>Osiris Therapeutics (<a href='https://seekingalpha.com/symbol/OSIR' title='Osiris Therapeutics, Inc.'>OSIR</a> <font color='red'>-18.8%</font>) continues its down move on more than 7x higher volume. Shares have lost over 45% of their value since last week when the company <a href=\"https://seekingalpha.com/pr/16768431-osiris-receives-notice-delisting-nasdaq\" target=\"_blank\">announced </a>that Nasdaq will suspend trading in its stock starting tomorrow. The exchange will also proceed with a formal delisting, effective 10 days after it files a Form 25 with the SEC.</li><li>After tomorrow, the stock will be quoted on the Pink OTC Markets (\"pink sheets\").</li></ul><div class=\"tiny-share-widget\" data-id=\"3250686\" data-linked=\"Trading in Osiris Therapeutics to be suspended tomorrow, formal delisting to follow; shares slump 19%\" data-tweet=\"$OSIR - Trading in Osiris Therapeutics to be suspended tomorrow, formal delisting to follow; shares slump 19% https://seekingalpha.com/news/3250686-trading-in-osiris-therapeutics-to-be-suspended-tomorrow-formal-delisting-to-follow-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3250686-trading-in-osiris-therapeutics-to-be-suspended-tomorrow-formal-delisting-to-follow-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250685\" data-ts=\"1489421833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPB\" target=\"_blank\">TPB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250685-turning-point-brands-rallies-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Turning Point Brands rallies after earnings</a></h4><ul> <li>Turning Point Brands (<a href='https://seekingalpha.com/symbol/TPB' title='Turning Point Brands'>TPB</a> <font color='green'>+6.8%</font>) moves higher after <a href=\"https://seekingalpha.com/pr/16768685-turning-point-brands-inc-reports-2016-fourth-quarter-full-year-results\" target=\"_blank\">Q4 revenue</a> came in ahead of estimates.</li> <li>Smokeless products sales for the year increased 4.9% to $77.9M, driven higher by the growth of Stoker moist smokeless tobacco.</li> <li>Stoker MST cass shipments were up by approximately 7% Y/Y.</li> <li>Overall demand was impacted during the quarter by a new $0.55 per ounce excise tax in Pennsylvania, which became effective on October 1.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3250551-turning-point-brands-eps-0_87\" target=\"_blank\">Turning Point Brands EPS of $0.87</a> (March 13)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250685\" data-linked=\"Turning Point Brands rallies after earnings\" data-tweet=\"$TPB - Turning Point Brands rallies after earnings https://seekingalpha.com/news/3250685-turning-point-brands-rallies-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3250685-turning-point-brands-rallies-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250681\" data-ts=\"1489421006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARLZ-OLD\" target=\"_blank\">ARLZ-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250681-aralez-q4-top-line-shy-of-consensus-shares-slump-29\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aralez Q4 top-line shy of consensus; shares slump 29%</a></h4><ul><li>Aralez Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ARLZ-OLD' title='Aralez Pharmaceuticals Inc.'>ARLZ-OLD</a> <font color='red'>-28.6%</font>)&nbsp;<a href=\"https://seekingalpha.com/pr/16768672-aralez-reports-fourth-quarter-full-year-2016-financial-results\" target=\"_blank\">Q4 results</a> ($M): 20.0 (+233.3%), consensus: 23.1.</li><li>Product revenues: 6.4; revenues from Toprol-XL and Zontivity: 8.6; VIMOVO royalties: 5.0.</li><li>Net Loss: (31.1) (-133.8%); Loss/Share: (0.48) (-20.0%).</li><li>$6.8M non-cash expense for amortization of intangible assets associated with Tribute, Zontivity and Toprol-XL plus $4.4M impairment charge related to Tribute intangible assets.</li><li><strong>2017 Guidance</strong>: Revenues: $80M - 100M; Non-GAAP EBITDA: Loss of ($25M - 10M).</li></ul><div class=\"tiny-share-widget\" data-id=\"3250681\" data-linked=\"Aralez Q4 top-line shy of consensus; shares slump 29%\" data-tweet=\"$ARLZ-OLD - Aralez Q4 top-line shy of consensus; shares slump 29% https://seekingalpha.com/news/3250681-aralez-q4-top-line-shy-of-consensus-shares-slump-29?source=tweet\" data-url=\"https://seekingalpha.com/news/3250681-aralez-q4-top-line-shy-of-consensus-shares-slump-29\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250678\" data-ts=\"1489420739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBLY\" target=\"_blank\">MBLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250678-citron-research-commends-mobileye-takeover-intel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron Research commends Mobileye takeover by Intel</a></h4><ul><li>Having communicated shift of short positioning in Nvidia to Mobileye (<a href='https://seekingalpha.com/symbol/MBLY' title='Mobileye'>MBLY</a> <font color='green'>+29.5%</font>) less than a month ago (though negative on shares <a href=\"https://twitter.com/CitronResearch/status/677162622416891904?ref_src=twsrc%5Etfw\" target=\"_blank\">for years</a>), firm remains mystified over deal pricing at approximately 30x 2017 revenue (as well as over volume of shares sold by management over public life of the company), though concedes it's <a href=\"https://twitter.com/CitronResearch/status/841282847310725121\" target=\"_blank\">\"undoubtedly Mobileye's day.\"</a></li><li>Previously (February 24, 2017): <a href=\"https://seekingalpha.com/news/3246432-mobileye-minus-3-percent-nvidia-plus-4-percent-intraday-citron-research-closing-nvidia-short\" target=\"_blank\">Mobileye -3%, Nvidia +4% intraday; Citron Research closing Nvidia short position, transferring to Mobileye</a></li><li>Earlier (March 13, 2017): <a href=\"https://seekingalpha.com/news/3250566-intel-confirms-acquisition-mobileye\" target=\"_blank\">Intel confirms acquisition of Mobileye</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3250678\" data-linked=\"Citron Research commends Mobileye takeover by Intel\" data-tweet=\"$MBLY - Citron Research commends Mobileye takeover by Intel https://seekingalpha.com/news/3250678-citron-research-commends-mobileye-takeover-intel?source=tweet\" data-url=\"https://seekingalpha.com/news/3250678-citron-research-commends-mobileye-takeover-intel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250677\" data-ts=\"1489420631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XL\" target=\"_blank\">XL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250677-xl-groupminus-1_8-after-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XL Group -1.8% after downgrade</a></h4><ul><li>Following about a 20% run higher in the stock over the past few months, Sandler O'Neill's Paul Newsome downgrades XL Group (<a href='https://seekingalpha.com/symbol/XL' title='XL Group plc'>XL</a> <font color='red'>-1.8%</font>) to Hold from Buy, and cuts the price target to $41 from $46.</li><li>Reinsurance markets remain very soft, he says, and he expects XL is set to benefit less than peers from tax reform.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250677\" data-linked=\"XL Group -1.8% after downgrade\" data-tweet=\"$XL - XL Group -1.8% after downgrade https://seekingalpha.com/news/3250677-xl-groupminus-1_8-after-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3250677-xl-groupminus-1_8-after-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250673\" data-ts=\"1489420187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXLG\" target=\"_blank\">DXLG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250673-destination-xl-group-spikes-canada-expansion-planned\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Destination XL Group spikes, Canada expansion planned</a></h4><ul> <li>Destination &nbsp;XL Group (NASDAQ:<a href='https://seekingalpha.com/symbol/DXLG' title='Destination XL Group, Inc.'>DXLG</a>) is <font color='green'>up 17%</font> after a mid-morning spike on strong volume.</li> <li>The company <a href=\"https://seekingalpha.com/pr/16769076-dxl-mens-apparel-opens-first-canadian-store-toronto-metro-area\" target=\"_blank\">announced</a> that it's entering the Canadian market with a DXL Men's Apparel store opening in Toronto. A second Canadian store is planned for April.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3250673\" data-linked=\"Destination XL Group spikes, Canada expansion planned\" data-tweet=\"$DXLG - Destination XL Group spikes, Canada expansion planned https://seekingalpha.com/news/3250673-destination-xl-group-spikes-canada-expansion-planned?source=tweet\" data-url=\"https://seekingalpha.com/news/3250673-destination-xl-group-spikes-canada-expansion-planned\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250669\" data-ts=\"1489419535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTE\" target=\"_blank\">PTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250669-shareholders-ok-majesco-entertainment-polarityte-combination\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shareholders OK Majesco Entertainment/PolarityTE combination</a></h4><ul>   <li>Shareholders have given final <a href=\"https://seekingalpha.com/pr/16768947-polarityte-tm-inc-stockholders-approve-merger\" target=\"_blank\">sign-off on a merger</a> between Majesco Entertainment and PolarityTE (<a href=\"https://seekingalpha.com/symbol/COOL\" target=\"_blank\">COOL</a> <font color='green'>+6.9%</font>), finalizing the videogame maker's transition toward a medical tissue company.</li>    <li>More than 99% of the represented 3,368,498 shares approved of the deal.</li>    <li>It's a \"significant milestone\" for the companies, says Chairman/CEO Denver Lough: \"We look forward to closing this merger and focusing exclusively on building Polarity into its full potential and beyond.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250669\" data-linked=\"Shareholders OK Majesco Entertainment/PolarityTE combination\" data-tweet=\"$PTE - Shareholders OK Majesco Entertainment/PolarityTE combination https://seekingalpha.com/news/3250669-shareholders-ok-majesco-entertainment-polarityte-combination?source=tweet\" data-url=\"https://seekingalpha.com/news/3250669-shareholders-ok-majesco-entertainment-polarityte-combination\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250667\" data-ts=\"1489419241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLTH\" target=\"_blank\">HLTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250667-nobilis-misses-on-q4-earnings-net-income-down-71-shares-slip-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nobilis misses on Q4 earnings, net income down 71%; shares slip 19%</a></h4><ul><li>Nobilis Health (<a href='https://seekingalpha.com/symbol/HLTH' title='Nobilis Health Corp.'>HLTH</a> <font color='red'>-19.2%</font>) slumps on more than a 4x surge in volume after it released <a href=\"https://seekingalpha.com/pr/16768668-nobilis-health-reports-fourth-quarter-2016-financial-results\" target=\"_blank\">Q4 results</a>. Revenues beat consensus by almost $3M but EPS fell short by nearly 43% ($0.12 versus consensus of $0.21).</li><li>Q4 numbers ($M):&nbsp;Revenues: 101.9 (+13.2%); Net Income: 13.6 (-71.2%); EPS: 0.12 (-79.3%).</li><li>CEO Harry Fleming says, \"Although we are pleased to report strong total revenue growth of 25% for full year 2016, we are disappointed that we did not meet the profitability goals we set out to achieve for the year. Full year Adjusted EBITDA was impacted by higher than expected marketing expenses and overall operating expenses.&nbsp; As we enter 2017, we will continue our mission to provide high quality surgical procedures across all of our brands and markets.&nbsp; We expect that the progress we have made integrating recently acquired facilities, coupled with the efforts to better target our marketing dollars and reduce certain operating expenses will support the strategic and financial goals for 2017.\"</li><li><strong>2017 Guidance</strong>: Revenues: $310M - 325M; Non-GAAP EBITDA: $40M - 45M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250667\" data-linked=\"Nobilis misses on Q4 earnings, net income down 71%; shares slip 19%\" data-tweet=\"$HLTH - Nobilis misses on Q4 earnings, net income down 71%; shares slip 19% https://seekingalpha.com/news/3250667-nobilis-misses-on-q4-earnings-net-income-down-71-shares-slip-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3250667-nobilis-misses-on-q4-earnings-net-income-down-71-shares-slip-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250663\" data-ts=\"1489418080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GES\" target=\"_blank\">GES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250663-wunderlich-still-positive-on-guess\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wunderlich still positive on Guess</a></h4><ul> <li>Wunderlich isn't throwing in the towel on its bullish view of Guess (<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='red'>-1%</font>), despite the sharp drop in share price from a year ago (-47%).</li> <li>\"While we fully admit that the domestic side of GUESS?'s business, like virtually every one else, remains highly challenged, we believe investors are ignoring multiple signs of a turn in the key (and higher-margin) European and Asian businesses, which have the ability to drive overall upside for the company,\" reads the firm's note.</li> <li>Wunderlich has a <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/03/9162673/guess-investors-are-ignoring-the-apparel-companys-europe\" target=\"_blank\">Buy rating</a> and $20 price target (+67% upside) on the retailer.</li> <li>Shares of Guess yield 7.55% to new buyers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250663\" data-linked=\"Wunderlich still positive on Guess\" data-tweet=\"$GES - Wunderlich still positive on Guess https://seekingalpha.com/news/3250663-wunderlich-still-positive-on-guess?source=tweet\" data-url=\"https://seekingalpha.com/news/3250663-wunderlich-still-positive-on-guess\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250661\" data-ts=\"1489417710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRK\" target=\"_blank\">GPRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250661-geoparkplus-10-after-j-p-morgan-says-buy-on-exploration-success\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GeoPark +10% after J.P. Morgan says Buy on exploration success</a></h4><ul><li>GeoPark (<a href='https://seekingalpha.com/symbol/GPRK' title='GeoPark Ltd.'>GPRK</a> <font color='green'>+10.3%</font>) surges as much as 31% to its highest since November 2014 after J.P. Morgan <a href=\"https://www.streetinsider.com/Analyst+Comments/JPMorgan+Upgrades+GeoPark+%28GPRK%29+to+Overweight/12659285.html\" target=\"_blank\">upgrades shares to Overweight</a> from Neutral with a $10 price target, double the firm's previous $5 target.</li><li>JPM says GPRK's proved exploratory success in Colombia increasing 2P reserves by 46% Y/Y,  increased production expectations and sound free cash flow generation in 2017-18 are  the main reasons supporting the upgrade.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250661\" data-linked=\"GeoPark +10% after J.P. Morgan says Buy on exploration success\" data-tweet=\"$GPRK - GeoPark +10% after J.P. Morgan says Buy on exploration success https://seekingalpha.com/news/3250661-geoparkplus-10-after-j-p-morgan-says-buy-on-exploration-success?source=tweet\" data-url=\"https://seekingalpha.com/news/3250661-geoparkplus-10-after-j-p-morgan-says-buy-on-exploration-success\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250656\" data-ts=\"1489417126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLS\" target=\"_blank\">NLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250656-nautilusplus-2-after-imperial-capital-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nautilus +2% after Imperial Capital upgrades</a></h4><ul> <li>Imperial Capital boosts its rating on Nautilus (<a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a> <font color='green'>+2.1%</font>) to Outperform from In-line on what the firm calls \"compelling\" valuation.</li> <li>The underleveraged balance sheet and free cash flow potential at Nautilus are seen as positive drivers for share price.</li> <li>The investment raises the <a href=\"https://www.streetinsider.com/Analyst+Comments/Imperial+Capital+Upgrades+Nautilus+%28NLS%29+to+Outperform+After+Hosting+Management+Meetings/12660685.html\" target=\"_blank\">price target</a> on the fitness products seller to $20 from $16.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3250656\" data-linked=\"Nautilus +2% after Imperial Capital upgrades\" data-tweet=\"$NLS - Nautilus +2% after Imperial Capital upgrades https://seekingalpha.com/news/3250656-nautilusplus-2-after-imperial-capital-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3250656-nautilusplus-2-after-imperial-capital-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250654\" data-ts=\"1489416603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLPH\" target=\"_blank\">DLPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250654-delphi-automotive-rallies-off-of-intel-mobileye-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delphi Automotive rallies off of Intel-Mobileye news</a></h4><ul> <li>Shares of Delphi Automotive (NYSE:<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a>) are <font color='green'>up 3.05%</font> in morning trading.</li><li>The company has partnerships with both Mobileye and Intel, two companies which announced a disruptive merger earlier today.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3250566-intel-confirms-acquisition-mobileye\" target=\"_blank\">Intel confirms acquisition of Mobileye</a> (March 13)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3250586-select-stocks-watch-monster-intel-mobileye-deal\" target=\"_blank\">Select stocks on watch after monster Intel-Mobileye deal</a> (March 13)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3250654\" data-linked=\"Delphi Automotive rallies off of Intel-Mobileye news\" data-tweet=\"$DLPH - Delphi Automotive rallies off of Intel-Mobileye news https://seekingalpha.com/news/3250654-delphi-automotive-rallies-off-of-intel-mobileye-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3250654-delphi-automotive-rallies-off-of-intel-mobileye-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250650\" data-ts=\"1489416192\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRGP\" target=\"_blank\">TRGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250650-targa-resources-upgraded-to-buy-from-hold-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Targa Resources upgraded to Buy from Hold at Stifel</a></h4><ul><li>Targa Resources (<a href='https://seekingalpha.com/symbol/TRGP' title='Targa Resources Corp.'>TRGP</a> <font color='green'>+1.9%</font>) is <a href=\"https://www.streetinsider.com/stock_lookup.php?LookUp=Get+Quote&amp;q=TRGP\" target=\"_blank\">upgraded to Buy</a> from Hold with a $65 price target, inched up from $64, at Stifel, citing TRGP's leading Permian gathering and processing footprint that supports volumes across its Gulf Coast natural gas liquids assets.</li><li>Stifel also says commentary at Enterprise Products Partners' recent analyst day supported  its belief that domestic LPG export volumes will remain solid.</li><li>Given that Stifel's fundamental thesis on TRGP has only strengthened, the firm believes the stock's recent pullback presents an attractive entry point for investors.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250650\" data-linked=\"Targa Resources upgraded to Buy from Hold at Stifel\" data-tweet=\"$TRGP - Targa Resources upgraded to Buy from Hold at Stifel https://seekingalpha.com/news/3250650-targa-resources-upgraded-to-buy-from-hold-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3250650-targa-resources-upgraded-to-buy-from-hold-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250644\" data-ts=\"1489415088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHP\" target=\"_blank\">BHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250644-global-miners-move-higher-china-affirms-capacity-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global miners move higher as China affirms capacity cuts</a></h4><ul>     <li>China's steel and iron ore futures resume their climb overnight, surging a respective 5.9% and 4.3%, after the head of China&rsquo;s Ministry of Information and Technology <a href=\"http://blogs.barrons.com/asiastocks/2017/03/13/chinas-steel-iron-ore-futures-rally-as-beijing-affirms-capacity-cuts/\" target=\"_blank\">reaffirmed</a> the government&rsquo;s resolve to <a href=\"https://seekingalpha.com/news/3248764-china-proposes-capacity-cuts-steel-coal\" target=\"_blank\">cut excess capacity</a> in the steel sector.</li>     <li>Today's strength also is attributed to seasonal demand, as Chinese <a href=\"http://in.reuters.com/article/asia-ironore-idINL3N1GQ1TC\" target=\"_blank\">construction activity picks up</a> after a slowdown over winter.</li>     <li>Among relevant tickers: <a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a> <font color='green'>+2.4%</font>, <a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='green'>+2.1%</font>, <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='green'>+3.5%</font>, <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='green'>+4.1%</font>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+4%</font>, <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+3.9%</font>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+4.2%</font>, <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+3%</font>, <a href='https://seekingalpha.com/symbol/WOR' title='Worthington Industries, Inc.'>WOR</a> <font color='green'>+2.7%</font>, <a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+2.3%</font>, <a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a> <font color='green'>+2.6%</font>, <a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='green'>+2.4%</font>, <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='green'>+1.7%</font>, <a href='https://seekingalpha.com/symbol/ACH' title='Aluminum Corporation of China Ltd'>ACH</a> <font color='green'>+1.2%</font>, <a href='https://seekingalpha.com/symbol/KALU' title='Kaiser Aluminum Corporation'>KALU</a> <font color='green'>+1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250644\" data-linked=\"Global miners move higher as China affirms capacity cuts\" data-tweet=\"$BHP $SLX $BHP - Global miners move higher as China affirms capacity cuts https://seekingalpha.com/news/3250644-global-miners-move-higher-china-affirms-capacity-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3250644-global-miners-move-higher-china-affirms-capacity-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250642\" data-ts=\"1489414133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROX\" target=\"_blank\">ROX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250642-castle-brands-pops-after-company-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Castle Brands pops after company presentation</a></h4><ul> <li>Castle Brands (NYSEMKT:<a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a>) is <font color='green'>up 12%</font> after the company presents at the 29th Annual Roth Conference.</li> <li>Management points out that Castle Brands trades at 2.7X revenue vs. the 5X-6X multiple typically seen with public drinks companies.</li> <li><a href=\"https://seekingalpha.com/filing/3457029\" target=\"_blank\">Castle Brands investor presentation</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3250642\" data-linked=\"Castle Brands pops after company presentation\" data-tweet=\"$ROX - Castle Brands pops after company presentation https://seekingalpha.com/news/3250642-castle-brands-pops-after-company-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3250642-castle-brands-pops-after-company-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250633\" data-ts=\"1489413585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FATE\" target=\"_blank\">FATE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250633-fate-therapeutics-cleared-to-begin-clinical-trial-assessing-nk-cell-therapy-in-blood-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fate Therapeutics cleared to begin clinical trial assessing NK cell therapy in blood cancer; shares up 9%</a></h4><ul><li>Thinly traded micro cap Fate Therapeutics (<a href='https://seekingalpha.com/symbol/FATE' title='Fate Therapeutics, Inc.'>FATE</a> <font color='green'>+9.4%</font>) jumps out the blocks on more than a 6x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/16768870-fate-therapeutics-announces-fda-clearance-investigational-new-drug-application-fate-nk100\" target=\"_blank\">announcement</a> that the FDA has approved its Investigational New Drug &#40;IND&#41; application for FATE-NK100, an adaptive memory natural killer &#40;NK&#41; cell product. The approval paves the way for a first-in-human clinical trial in patients with advanced acute myeloid leukemia &#40;AML&#41;.</li><li>The early-stage study, to be conducted at the University of Minnesota, will determine the maximum tolerated dose of a single intravenous administration of FATE-NK100 in an accelerated dose escalation design in four patients.</li><li>FATE-NK100 is a <a href=\"http://fatetherapeutics.com/cell-programming/\" target=\"_blank\">next-generation immunotherapy</a> based on a subset of NK cells that have shown robust anti-tumor activity in addition to promoting endogenous T cell response while resisting immune checkpoints.</li><li>NK cells identify and kill cancer cells by recognizing a range of stress signals expressed on tumor cells. Normal healthy cells are unaffected/unharmed. This is a different mechanism of action compared to T cells which require a specific tumor antigen to elicit an immune response and must be customized for each patient. The company says a significant advantage of NK-based immunotherapy is the avoidance of graft-versus-host disease, a common and potentially serious side-effect of T cell therapies.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250633\" data-linked=\"Fate Therapeutics cleared to begin clinical trial assessing NK cell therapy in blood cancer; shares up 9%\" data-tweet=\"$FATE - Fate Therapeutics cleared to begin clinical trial assessing NK cell therapy in blood cancer; shares up 9% https://seekingalpha.com/news/3250633-fate-therapeutics-cleared-to-begin-clinical-trial-assessing-nk-cell-therapy-in-blood-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3250633-fate-therapeutics-cleared-to-begin-clinical-trial-assessing-nk-cell-therapy-in-blood-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250639\" data-ts=\"1489413430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNRT\" target=\"_blank\">GNRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250639-post-earnings-rally-for-gener8-maritime\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings rally for Gener8 Maritime</a></h4><ul> <li>Gener8 Maritime (<a href='https://seekingalpha.com/symbol/GNRT' title='Gener8 Maritime'>GNRT</a> <font color='green'>+9.7%</font>) breaks higher after the company tops Q4 estimates.</li> <li>The full fleet TCE rate for the quarter was $28,190 vs. $40,236 last year.</li> <li>Net voyage revenue was flat compared to last year at $99.6M.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3250526-gener8-maritime-beats-0_07-beats-revenue\" target=\"_blank\">Gener8 Maritime beats by $0.07, beats on revenue</a> (March 13)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250639\" data-linked=\"Post-earnings rally for Gener8 Maritime\" data-tweet=\"$GNRT - Post-earnings rally for Gener8 Maritime https://seekingalpha.com/news/3250639-post-earnings-rally-for-gener8-maritime?source=tweet\" data-url=\"https://seekingalpha.com/news/3250639-post-earnings-rally-for-gener8-maritime\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250632\" data-ts=\"1489412243\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAV\" target=\"_blank\">NAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250632-icahn-boosts-stake-in-navistar-to-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Icahn boosts stake in Navistar to 17%</a></h4><ul><li>Carl Icahn has raised his stake in truck maker Navistar (<a href='https://seekingalpha.com/symbol/NAV' title='Navistar International Corporation'>NAV</a> <font color='green'>+3.4%</font>) to 17.02%, according to an <a href=\"https://www.sec.gov/Archives/edgar/data/808450/000092846417000018/navsch13damd21031017.htm\" target=\"_blank\">SEC filing</a>.</li><li>That was up from the 16.61% stake the company previously reported as of February 28.</li><li>Last week, Navistar <a href=\"https://seekingalpha.com/news/3249033-navistar-misses-0_33-misses-revenue\" target=\"_blank\">reported</a> a much wider-than-expected quarterly loss on continued industry weakness, but said its new product line is positioned well for an expected market rebound in the second half of 2017.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250632\" data-linked=\"Icahn boosts stake in Navistar to 17%\" data-tweet=\"$NAV - Icahn boosts stake in Navistar to 17% https://seekingalpha.com/news/3250632-icahn-boosts-stake-in-navistar-to-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3250632-icahn-boosts-stake-in-navistar-to-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250631\" data-ts=\"1489412008\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250631-morgan-stanley-sees-positive-trends-for-wynn-resorts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley sees positive trends for Wynn Resorts</a></h4><ul> <li>Morgan Stanley backs up it bullish call on Wynn Resorts (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='green'>+3.6%</font>) in a fresh note issued this morning. The best case scenario from MS has Wynn doubling in share price to <a href=\"https://www.streetinsider.com/Analyst+Comments/Street+Underestimating+Wynn+%28WYNN%29+Market+Share+Gains+In+Macau+-+Morgan+Stanley/12660154.html\" target=\"_blank\">$200</a>, while the one-year price target is $119.</li> <li>\"Macau gaming revenue rose 10% in 4Q16, and 11% YTD. We expect high-single-digit growth going forward. The growth is being driven by spend per visitor recovering rapidly, a demographic shift that plays into WYNN's premium positioning,\" writes analyst Thomas Allen.</li> <li>A dig into Google trends shows a huge uptick in searches for Wynn's properties since the opening of Wynn Palace. The long-term potential of the Boston project also plays into Morgan's thesis.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3250631\" data-linked=\"Morgan Stanley sees positive trends for Wynn Resorts\" data-tweet=\"$WYNN - Morgan Stanley sees positive trends for Wynn Resorts https://seekingalpha.com/news/3250631-morgan-stanley-sees-positive-trends-for-wynn-resorts?source=tweet\" data-url=\"https://seekingalpha.com/news/3250631-morgan-stanley-sees-positive-trends-for-wynn-resorts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250628\" data-ts=\"1489411631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250628-amgens-repatha-reduces-need-for-apheresis-in-patients-high-bad-cholesterol-in-late-stage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amgen&#39;s Repatha reduces need for apheresis in patients with high &quot;bad&quot; cholesterol in late-stage study; shares ahead 1% premarket</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/16769118-repatha-evolocumab-demonstrates-reduced-need-apheresis-patients-high-ldl-cholesterol-phase-3\" target=\"_blank\">Results from a Phase 3 clinical trial</a> showed patients with abnormally elevated levels of low-density lipoprotein cholesterol (LDL-C) who were receiving apheresis to lower their levels of \"bad\" cholesterol significantly reduced their need for the plasma-cleansing procedure by taking Repatha (evolocumab).</li><li>The study involved 39 patients with LDL-C levels between 100 mg/dL and 190 mg/dL (optimal is less than 100 mg/dL) despite undergoing apheresis once or twice per week. They were randomized to receive either Repatha every two weeks or continue apheresis for six weeks. After the six-week period, all received Repatha.</li><li>Detailed results will be submitted for publication and for presentation at an upcoming medical conference.</li><li>Shares are up&nbsp;<font color='green'>1%&nbsp;</font>premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250628\" data-linked=\"Amgen&#39;s Repatha reduces need for apheresis in patients with high &quot;bad&quot; cholesterol in late-stage study; shares ahead 1% premarket\" data-tweet=\"Amgen&#39;s Repatha reduces need for apheresis in patients with high &quot;bad&quot; cholesterol in late-stage study; shares ahead 1% premarket https://seekingalpha.com/news/3250628-amgens-repatha-reduces-need-for-apheresis-in-patients-high-bad-cholesterol-in-late-stage?source=tweet\" data-url=\"https://seekingalpha.com/news/3250628-amgens-repatha-reduces-need-for-apheresis-in-patients-high-bad-cholesterol-in-late-stage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250626\" data-ts=\"1489411431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250626-frontier-communicationsminus-2_6-after-s-and-p-500-ouster\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier Communications -2.6% after S&amp;P 500 ouster</a></h4><ul>   <li>Frontier Communications (NYSE:<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>) is <font color='red'>2.6% lower</font> premarket following weekend news that it's <a href=\"https://seekingalpha.com/news/3250495-amd-rjf-moving-s-and-p-index-market-cap-changes-shuffle-tickers\" target=\"_blank\">exiting the S&amp;P 500</a> as part of index rebalancing.</li>    <li>S&amp;P Dow Jones Indices reset the market capitalization levels at which it defines members of the S&amp;P 500, the S&amp;P MidCap 400, and the S&amp;P SmallCap 600.</li>    <li>As a result, Frontier moved out (along with Urban Outfitters and First Solar) to make room for new 500 members AMD, Raymond James Financial and Alexandria Real Estate Equities.</li>    <li>Frontier's market cap of $3.2B is below S&amp;P's current guideline that companies in the 500 have a cap of $6.1B or more.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250626\" data-linked=\"Frontier Communications -2.6% after S&amp;P 500 ouster\" data-tweet=\"$FTR - Frontier Communications -2.6% after S&amp;P 500 ouster https://seekingalpha.com/news/3250626-frontier-communicationsminus-2_6-after-s-and-p-500-ouster?source=tweet\" data-url=\"https://seekingalpha.com/news/3250626-frontier-communicationsminus-2_6-after-s-and-p-500-ouster\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250621\" data-ts=\"1489410746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250621-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MBLY' title='Mobileye'>MBLY</a> <font color='green'>+30%</font>. CERU <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/CVRS' title='Corindus Vascular Robotics, Inc.'>CVRS</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/FATE' title='Fate Therapeutics, Inc.'>FATE</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='green'>+9%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/MTL' title='Mechel OAO'>MTL</a>&nbsp;<font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a>&nbsp;<font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a>&nbsp;<font color='green'>+6%</font>. ITEK&nbsp;<font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CEMP' title='Cempra, Inc.'>CEMP</a>&nbsp;<font color='green'>+6%</font>.</li>     <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HLTH' title='Nobilis Health Corp.'>HLTH</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/CERC' title='Cerecor'>CERC</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/PRKR' title='ParkerVision, Inc.'>OTC:PRKR</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ARLZ-OLD' title='Aralez Pharmaceuticals Inc.'>ARLZ-OLD</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/EVOK' title='Evoke Pharma, Inc.'>EVOK</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250621\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$MBLY $DARE $CVRS - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3250621-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3250621-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250617\" data-ts=\"1489410366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNSR\" target=\"_blank\">FNSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250617-finisar-upgraded-to-strong-buy-raymond-james\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finisar upgraded to Strong Buy at Raymond James</a></h4><ul><li>Elevating from Outperform, <a href=\"http://www.streetinsider.com/Analyst+Comments/Raymond+James+Upgrades+Finisar+%28FNSR%29+to+Strong+Buy%2C+Admits+To+Envisioning+%22significant+upside+potential%22/12658887.html\" target=\"_blank\">analyst Simon Leopold</a> acknowledges Finisar's execution issues, though considers these largely \"misunderstood or exaggerated.\"</li><li>Views resolution of problems with a primary customer as well as potential among 100G data center and 3D sensing as catalysts, while noting firm's optimistic on next week's <a href=\"http://www.ofcconference.org/en-us/home/\" target=\"_blank\">OFC Conference</a>&nbsp;and the opportunity it presents for greater insight into the overall optical market.</li><li>Price target $40. Finisar (NASDAQ:<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a>) $27.25,&nbsp;<font color='green'>+1%</font>&nbsp;pre-market (<font color='red'>-20%+</font>&nbsp;since reporting Q3 2017 last Thursday).</li><li>Last week &ndash;&nbsp;<a href=\"https://seekingalpha.com/news/3250441-finisar-widely-reissued-bullishly-amid-21-percent-decline\" target=\"_blank\">Finisar widely reissued bullishly amid 21%+ decline</a> (March 10) /&nbsp;<a href=\"https://seekingalpha.com/news/3250166-optical-component-makers-reduce-hours-subsequent-negative-finisar-reporting\" target=\"_blank\">Optical component makers reduce after hours subsequent negative Finisar reporting</a>&nbsp;(March 9) /&nbsp;<a href=\"https://seekingalpha.com/news/3250146-finisar-minus-16_2-percent-q3-2017-fy-outlook-expectations\" target=\"_blank\">Finisar -16.2%; Q3 2017, FY outlook off expectations</a>&nbsp;(March 9) / <a href=\"https://seekingalpha.com/article/4053963-finisar-corps-fnsr-ceo-jerry-rawls-q3-2017-results-earnings-call-transcript\" target=\"_blank\">earnings call transcript</a> (March 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3250617\" data-linked=\"Finisar upgraded to Strong Buy at Raymond James\" data-tweet=\"$FNSR - Finisar upgraded to Strong Buy at Raymond James https://seekingalpha.com/news/3250617-finisar-upgraded-to-strong-buy-raymond-james?source=tweet\" data-url=\"https://seekingalpha.com/news/3250617-finisar-upgraded-to-strong-buy-raymond-james\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250606\" data-ts=\"1489408894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250606-marvell-technology-group-upgraded-to-buy-needham-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marvell Technology Group upgraded to Buy at Needham &amp; Company</a></h4><ul><li>From Hold and following the company's <a href=\"http://investor.marvell.com/phoenix.zhtml?p=irol-eventDetails&amp;c=120802&amp;eventID=5246758\" target=\"_blank\">investor day</a>&nbsp;event held last Friday, <a href=\"http://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Upgrades+Marvell+%28MRVL%29+to+Buy/12659497.html\" target=\"_blank\">analyst Quinn Bolton</a> highlights Marvell Technology Group's new management team, opportunities for growth generation among storage, networking and connectivity segments, as well as plans for greater capital returns, which combined with accretive M&amp;A prospects, strengthens upside potential.</li><li>Price target $21. Marvell Technology Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a>) $16.85,&nbsp;<font color='green'>+2.81%</font>&nbsp;pre-market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250606\" data-linked=\"Marvell Technology Group upgraded to Buy at Needham &amp; Company\" data-tweet=\"$MRVL - Marvell Technology Group upgraded to Buy at Needham &amp; Company https://seekingalpha.com/news/3250606-marvell-technology-group-upgraded-to-buy-needham-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3250606-marvell-technology-group-upgraded-to-buy-needham-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250600\" data-ts=\"1489408710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEMP\" target=\"_blank\">CEMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250600-cempra-engages-morgan-stanley-to-assist-in-strategic-review-shares-ahead-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cempra engages Morgan Stanley to assist in strategic review; shares ahead 4% premarket</a></h4><ul><li>Cempra (NASDAQ:<a href='https://seekingalpha.com/symbol/CEMP' title='Cempra, Inc.'>CEMP</a>) perks up&nbsp;<font color='green'>4%</font>&nbsp;premarket on modest volume in response to its <a href=\"https://seekingalpha.com/pr/16768733-cempra-retains-morgan-stanley-lead-review-strategic-business-options\" target=\"_blank\">announcement </a>that it has retained Morgan Stanley as a financial advisor as it reviews strategic alternatives.</li><li>The company says it has no specific timetable for the process and will not disclose further developments until the board has approved a specific action. As of year-end 2016, its quick assets totaled $231.6M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250600\" data-linked=\"Cempra engages Morgan Stanley to assist in strategic review; shares ahead 4% premarket\" data-tweet=\"$CEMP - Cempra engages Morgan Stanley to assist in strategic review; shares ahead 4% premarket https://seekingalpha.com/news/3250600-cempra-engages-morgan-stanley-to-assist-in-strategic-review-shares-ahead-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3250600-cempra-engages-morgan-stanley-to-assist-in-strategic-review-shares-ahead-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>133&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250590\" data-ts=\"1489407860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250590-icahn-adds-to-herbalife-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Icahn adds to Herbalife stake</a></h4><ul><li>Herbalife (NYSE:<a href='https://seekingalpha.com/symbol/HLF' title='Herbalife Ltd.'>HLF</a>) perks up&nbsp;<font color='green'>1%</font>&nbsp;premarket,albeit on only 1,100 shares, in response to the news that activist investor Carl Icahn has added ~372K shares to his 22M+ stake in the firm.</li><li>Source: StreetInsider</li></ul><div class=\"tiny-share-widget\" data-id=\"3250590\" data-linked=\"Icahn adds to Herbalife stake\" data-tweet=\"$HLF - Icahn adds to Herbalife stake https://seekingalpha.com/news/3250590-icahn-adds-to-herbalife-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3250590-icahn-adds-to-herbalife-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>329&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250587\" data-ts=\"1489407633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250587-boeing-dips-after-morgan-stanley-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing dips after Morgan Stanley downgrade</a></h4><ul><li>Boeing (NYSE:<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a>) <font color='red'>-1%</font> premarket after Morgan Stanley <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Morgan+Stanley+Downgrades+Boeing+%28BA%29+to+Equalweight/12658975.html\" target=\"_blank\">lowered</a> the planemaker's stock to Equal Weight from Overweight, with a price target of $190 (from $185).</li><li>\"For the rest of 2017, BA has several risks and opportunities. Aircraft order flow will likely remain light and with a book to bill in the sub-1x range, while the backlog faces risk around a more subdued airline profit environment... Looking forward, despite the rest of 2017 being mixed, the longer-term narrative is impressive on cash flow and growth.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3250587\" data-linked=\"Boeing dips after Morgan Stanley downgrade\" data-tweet=\"$BA - Boeing dips after Morgan Stanley downgrade https://seekingalpha.com/news/3250587-boeing-dips-after-morgan-stanley-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3250587-boeing-dips-after-morgan-stanley-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250586\" data-ts=\"1489407504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALV\" target=\"_blank\">ALV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250586-select-stocks-on-watch-after-monster-intel-mobileye-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select stocks on watch after monster Intel-Mobileye deal</a></h4><ul> <li>Shares of Autoliv (NYSE:<a href='https://seekingalpha.com/symbol/ALV' title='Autoliv Inc.'>ALV</a>) are <font color='green'>up 2.47%</font> in premarket trading after Intel ponies up $15.3B to acquire Mobileye.</li> <li>Infineon Technologies (<a href='https://seekingalpha.com/symbol/IFNNF' title='Infineon Technologies AG'>OTCQX:IFNNF</a>) and STMicroelectronics (NYSE:<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a>) are both on watch for volatility after the monster Intel deal.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3250566-intel-confirms-acquisition-mobileye\" target=\"_blank\">Intel confirms acquisition of Mobileye</a> (March 13)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3250586\" data-linked=\"Select stocks on watch after monster Intel-Mobileye deal\" data-tweet=\"$ALV $ALV $IFNNF - Select stocks on watch after monster Intel-Mobileye deal https://seekingalpha.com/news/3250586-select-stocks-on-watch-after-monster-intel-mobileye-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3250586-select-stocks-on-watch-after-monster-intel-mobileye-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250573\" data-ts=\"1489406184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTBX\" target=\"_blank\">HTBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250573-heat-biologics-advances-hsminus-110-to-phase-2-development-shares-jump-56-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heat Biologics advances HS-110 to Phase 2 development; shares jump 56% premarket</a></h4><ul><li>Nano cap Heat Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a>) rockets&nbsp;<font color='green'>56%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16768722-heat-biologics-meets-efficacy-endpoint-phase-1b-lung-cancer-trial-progress-phase-2\" target=\"_blank\">announcement</a> of successful results from a Phase 1b study assessing the combination of HS-110 and Bristol-Myers Squibb's (NYSE:<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a>) Opdivo (nivolumab) in non-small cell lung cancer &#40;NSCLC&#41;. The study met is safety endpoint by demonstrating no new toxicities compared to existing data on nivolumab alone. In addition, 33% of patients (n=5/15) experienced at least a 20% reduction in tumor size.</li><li>Daniel Morgensztern, M.D., Associate Professor of Medicine and Director of Thoracic Oncology, Washington University School of Medicine says, &ldquo;We are encouraged by the results from this Phase 1b trial evaluating the therapeutic vaccine, HS-110, combined with the checkpoint inhibitor, nivolumab, in patients with advanced NSCLC. We continue to see that the combination appears to be generally well-tolerated, and the encouraging signs of efficacy warrant a larger sample size. We&rsquo;ve seen some patients with increased tumor infiltrating lymphocytes after treatment, and anticipate that we can confirm this trend in the Phase 2.&rdquo;</li><li>The results are good news for stockholders. Shares plummeted in December after lead product candidate HS-410 failed to beat placebo in a mid-stage bladder cancer study.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3227997-heat-biologics-lead-product-candidate-flunks-mid-stage-bladder-cancer-study-shares-plummet-56\" target=\"_blank\">Heat Biologics' lead product candidate flunks mid-stage bladder cancer study; shares plummet 56%</a> (Dec. 1, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3250573\" data-linked=\"Heat Biologics advances HS-110 to Phase 2 development; shares jump 56% premarket\" data-tweet=\"$HTBX $HTBX $BMY - Heat Biologics advances HS-110 to Phase 2 development; shares jump 56% premarket https://seekingalpha.com/news/3250573-heat-biologics-advances-hsminus-110-to-phase-2-development-shares-jump-56-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3250573-heat-biologics-advances-hsminus-110-to-phase-2-development-shares-jump-56-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250566\" data-ts=\"1489405052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250566-intel-confirms-acquisition-of-mobileye\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel confirms acquisition of Mobileye</a></h4><ul>          <li>Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) acquires Mobileye (NYSE:<a href='https://seekingalpha.com/symbol/MBLY' title='Mobileye'>MBLY</a>) for $63.54 per share.</li>     <li>The company says the $15.3B deal&nbsp;will position it as a leading technology provider in the autonomous vehicle industry, seen as a $70B market by 2030.</li>     <li>The acquisition is expected to be accretive to Intel's EPS and free cash flow immediately.</li>     <li>The transaction is expected to close within the next nine months.</li><li>INTC  <font color='red'>-1.61%</font> premarket to  $35.33. MBLY&nbsp;<font color='green'>+33.30%</font>&nbsp;to $63.01.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/16768758-intel-acquire-mobileye\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3250499-sleep-self-driving-car-revolution\" target=\"_blank\">Don't sleep on the self-driving car revolution</a> (March 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250566\" data-linked=\"Intel confirms acquisition of Mobileye\" data-tweet=\"$INTC $INTC $MBLY - Intel confirms acquisition of Mobileye https://seekingalpha.com/news/3250566-intel-confirms-acquisition-of-mobileye?source=tweet\" data-url=\"https://seekingalpha.com/news/3250566-intel-confirms-acquisition-of-mobileye\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250560\" data-ts=\"1489404255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250560-seadrill-gets-170m-in-west-mira-rig-dispute-settlement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill gets $170M in West Mira rig dispute settlement</a></h4><ul><li>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a>) <font color='green'>+11.3%</font> premarket after saying it will <a href=\"https://globenewswire.com/news-release/2017/03/13/934780/0/en/SDRL-Seadrill-Limited-Announces-Settlement-of-West-Mira-Arbitration.html\" target=\"_blank\">receive a $170M settlement</a> from Hyundai Samho Heavy Industries in the arbitration related to the <em>West Mira</em> rig.</li><li>SDRL canceled its construction contract for the <em> West Mira</em>, leading to arbitration proceedings in October 2015 that were expected to conclude during H1 2018.</li><li>As part of the settlement, Seatankers - another John Fredriksen company - will acquire the rig from the shipyard.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250560\" data-linked=\"Seadrill gets $170M in West Mira rig dispute settlement\" data-tweet=\"$SDRL - Seadrill gets $170M in West Mira rig dispute settlement https://seekingalpha.com/news/3250560-seadrill-gets-170m-in-west-mira-rig-dispute-settlement?source=tweet\" data-url=\"https://seekingalpha.com/news/3250560-seadrill-gets-170m-in-west-mira-rig-dispute-settlement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250557\" data-ts=\"1489403666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIG\" target=\"_blank\">AIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250557-aigminus-1-deutsche-bank-downgrades-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AIG -1% as Deutsche Bank downgrades to Sell</a></h4><ul><li>Last week's decision to axe CEO Peter Hancock isn't impressing the team at Deutsche Bank, which downgrades <a href='https://seekingalpha.com/symbol/AIG' title='American International Group Inc'>AIG</a> to Sell from Hold. The <a href=\"https://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Downgrades+American+International+Group+%28AIG%29+to+Sell/12658978.html\" target=\"_blank\">new price target of $57</a> (from $61) suggests&nbsp;<font color='red'>about 10% downside</font>&nbsp;from Friday's close.</li><li>Shares&nbsp;<font color='red'>-1%</font>&nbsp;premarket to $62.45.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250557\" data-linked=\"AIG -1% as Deutsche Bank downgrades to Sell\" data-tweet=\"$AIG - AIG -1% as Deutsche Bank downgrades to Sell https://seekingalpha.com/news/3250557-aigminus-1-deutsche-bank-downgrades-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3250557-aigminus-1-deutsche-bank-downgrades-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250541\" data-ts=\"1489401926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMFW\" target=\"_blank\">AMFW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250541-amec-foster-wheeler-agrees-to-takeover-offer-from-john-wood\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amec Foster Wheeler agrees to takeover offer from John Wood</a></h4><ul>     <li>Amec Foster Wheeler (NYSE:<a href='https://seekingalpha.com/symbol/AMFW' title='Amec Foster Wheeler plc'>AMFW</a>) jumps as much as 23% in London trading after <a href=\"http://www.bbc.com/news/business-39253416\" target=\"_blank\">accepting</a> a &pound;2.23B ($2.73B) all-share <a href=\"https://www.woodgroup.com/press/press-releases/2017/march-2017-update\" target=\"_blank\">takeover offer</a> from John Wood Group (<a href='https://seekingalpha.com/symbol/WDGJF' title='Wood Group &#40;John&#41; Plc.'>OTCPK:WDGJF</a>).</li>     <li>AMFW shareholders would get 0.75 new Wood Group shares for each share held, valuing their existing  shares at 564 pence, and giving them 44% of the combined group; the  offer price is a 15% premium to AMFW&nbsp;Friday closing price of  489.2 pence.</li>     <li>In its offer, Wood says it hopes to cut &pound;110M in costs out of the combined company, which will provide services to oil and gas, chemicals and mining  sectors.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250541\" data-linked=\"Amec Foster Wheeler agrees to takeover offer from John Wood\" data-tweet=\"$AMFW $AMFW $WDGJF - Amec Foster Wheeler agrees to takeover offer from John Wood https://seekingalpha.com/news/3250541-amec-foster-wheeler-agrees-to-takeover-offer-from-john-wood?source=tweet\" data-url=\"https://seekingalpha.com/news/3250541-amec-foster-wheeler-agrees-to-takeover-offer-from-john-wood\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250531\" data-ts=\"1489400219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250531-report-intel-to-buy-mobileye-for-14b-15b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Intel to buy Mobileye for $14B-$15B</a></h4><ul><li>The biggest deal in the history of Israel's high-tech industry will be <a href=\"http://www.cnbc.com/2017/03/13/intel-to-buy-mobileye-for-14-billion-to-15-billion-israeli-media-report.html\" target=\"_blank\">announced</a> in the coming hours, according to <i>TheMarker</i>, one of Israel's leading financial newspapers.</li><li>Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) has reportedly agreed to buy Mobileye (NYSE:<a href='https://seekingalpha.com/symbol/MBLY' title='Mobileye'>MBLY</a>), a leading manufacturer of software for autonomous vehicles, for $14B-$15B.</li><li>MBLY <font color='green'>+29%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3250531\" data-linked=\"Report: Intel to buy Mobileye for $14B-$15B\" data-tweet=\"$INTC $INTC $MBLY - Report: Intel to buy Mobileye for $14B-$15B https://seekingalpha.com/news/3250531-report-intel-to-buy-mobileye-for-14b-15b?source=tweet\" data-url=\"https://seekingalpha.com/news/3250531-report-intel-to-buy-mobileye-for-14b-15b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":63,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}